In the United States, hantavirus infections average around 20–40 cases per year — rare enough that most emergency physicians will see only a handful in their careers, but lethal enough that missing the diagnosis is catastrophic. The CDC reports a case fatality rate of approximately 36% for US Hantavirus Pulmonary Syndrome (HPS). Here is what clinicians actually see when a case presents, and how to distinguish it from far more common respiratory illnesses.
The US Strain: Sin Nombre Virus
The dominant hantavirus in the United States is Sin Nombre virus (SNV), carried primarily by the deer mouse (Peromyscus maniculatus) across the American West. Cases are concentrated in the Four Corners region (New Mexico, Arizona, Colorado, Utah), but deer mice range across virtually the entire continental US.
The 2026 MV Hondius outbreak involves Andes virus — a South American strain — and includes one confirmed US case. That patient is being managed under CDC protocols originally developed for Sin Nombre, as both viruses cause HPS with nearly identical clinical presentations.
The Typical Presentation US Doctors See
Day 1–3 of symptoms: A previously healthy adult (median age 37 in CDC data) presents to an urgent care or emergency department with:
- Fever (temperature 38.5–40°C / 101–104°F)
- Diffuse myalgia — classically affecting the large muscle groups, particularly thighs and lower back. Patients describe it as “the worst muscle aches I’ve ever had”
- Fatigue — often the chief complaint. Many patients report they “can’t get up”
- Headache — present in about 70% of cases
What is absent and diagnostically significant:
- No sore throat
- No runny nose
- No significant upper respiratory symptoms
- No lymphadenopathy
An experienced clinician who hears “flu-like illness without URI symptoms” in a patient from an endemic region will immediately ask about rodent exposure.
The Question Every US Doctor Should Ask
“Have you been in any barns, cabins, sheds, or other enclosed spaces that might have had rodent activity in the past 6 weeks?”
This single question changes the diagnostic workup. A positive answer — or a history of cleaning out a rodent-infested space, handling dead rodents, or camping in the rural Southwest — warrants immediate hantavirus evaluation.
In 2026, a new exposure scenario has entered the differential: “Were you a passenger or crew member on the MV Hondius cruise ship between January and May 2026?”
Laboratory Findings: What the Tests Show
US hospitals can confirm hantavirus through CDC-developed serology (IgM antibody) and PCR testing. But certain routine labs suggest the diagnosis before confirmatory results return:
Complete Blood Count:
- Thrombocytopenia — low platelets; present in >95% of HPS cases, often the first lab abnormality
- Haemoconcentration — elevated haematocrit as plasma leaks into the lungs
- Left shift — elevated white cell count with bands (immature neutrophils)
- Immunoblasts — large activated lymphocytes; highly specific for HPS, seen in ~70% of cases on peripheral blood smear
Chemistry:
- Elevated LDH (lactate dehydrogenase)
- Mildly elevated creatinine
- Hypoalbuminaemia (low albumin as protein leaks)
Chest X-ray:
- Early: normal or subtle bilateral haziness
- Progressive: bilateral interstitial infiltrates (“bat-wing” pattern)
- Advanced: “whiteout” — complete bilateral opacification
An emergency physician who sees thrombocytopenia + haemoconcentration + bilateral infiltrates in a febrile patient from the rural West has a hantavirus case until proven otherwise.
How US Doctors Differentiate HPS from Other Conditions
From influenza:
- Flu causes upper respiratory symptoms (sore throat, nasal congestion) — HPS does not
- Flu thrombocytopenia is mild and transient — HPS thrombocytopenia is severe and worsening
- Flu bilateral infiltrates are late findings — HPS infiltrates appear earlier in disease course
From COVID-19:
- COVID causes loss of taste/smell — HPS does not
- COVID has a longer prodromal period — HPS cardiopulmonary deterioration is more abrupt
- COVID serology distinguishes the two definitively
From community-acquired pneumonia (CAP):
- CAP typically causes unilateral or lobar infiltrates — HPS is bilateral
- CAP patients often have productive cough — HPS cough is dry
- CAP responds to antibiotics — HPS does not
From ARDS from other causes:
- Clinical context is key: rodent exposure history + thrombocytopenia + immunoblasts = HPS
- No rodent exposure + prior infection/aspiration/trauma = other ARDS cause
The Triage Decision: When to Escalate Fast
US emergency physicians who suspect HPS should escalate immediately rather than observe. Key decision points:
| Finding | Action |
|---|---|
| Thrombocytopenia (<150K) + fever + myalgia + rural exposure | Admit, notify ID, order hantavirus serology + CBC every 4 hours |
| Any bilateral infiltrates on CXR | ICU transfer, alert pulmonology |
| O2 sat <94% | Immediate ICU, prepare for intubation |
| Haematocrit rising rapidly | Impending shock — activate ECMO team if available |
The CDC recommends that any suspected HPS case be managed at a facility with mechanical ventilation capability. If ECMO is available, early consultation should be established before the patient deteriorates — not after.
Geographic Risk: Where US Cases Cluster
CDC surveillance data shows consistent geographic clustering:
- Four Corners region: New Mexico, Arizona, Colorado, Utah — historically the highest density
- Pacific Northwest: Washington, Oregon, northern California
- Texas: Scattered cases, primarily in rural areas
- Montana/Wyoming: Cases associated with agricultural and recreational exposure
California’s Sierra Nevada range warrants specific attention: deer mouse populations are high, and cabin/recreational exposure is common. The Yosemite outbreak of 2012 — which infected 10 people and killed 3 — demonstrated how a popular tourist destination could produce a cluster.
Outside the West, HPS is rare but possible. The deer mouse range extends to the East Coast, and cases have occurred in states including Florida (Bayou virus) and Louisiana.
What US Patients Need to Know
If you live in or have visited a rural area of the American West and develop severe flu-like illness without sore throat or runny nose, tell your doctor about any potential rodent exposure immediately. Do not wait for respiratory symptoms to develop.
The US healthcare system has strong HPS management protocols. The CDC maintains 24/7 consultation for clinicians through its Emergency Operations Center. The key is getting the right information to the right people before the cardiopulmonary phase begins.
See current US hantavirus cases on our live map →
Explore HantavirusMap